Literature DB >> 23846436

Mitral valve closure prediction with 3-D personalized anatomical models and anisotropic hyperelastic tissue assumptions.

C Sprouse, R Mukherjee, P Burlina.   

Abstract

This study is concerned with the development of patient-specific simulations of the mitral valve that use personalized anatomical models derived from 3-D transesophageal echocardiography (3-D TEE). The proposed method predicts the closed configuration of the mitral valve by solving for an equilibrium solution that balances various forces including blood pressure, tissue collision, valve tethering, and tissue elasticity. The model also incorporates realistic hyperelastic and anisotropic properties for the valve leaflets. This study compares hyperelastic tissue laws with a quasi-elastic law under various physiological parameters, and provides insights into error sensitivity to chordal placement, allowing for a preliminary comparison of the influence of the two factors (chords and models) on error. Predictive errors show the promise of the method, yielding aggregate median errors of the order of 1 mm, and computed strains and stresses show good correspondence with those reported in prior studies.

Entities:  

Mesh:

Year:  2013        PMID: 23846436     DOI: 10.1109/TBME.2013.2272075

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  2 in total

1.  Modeling the Myxomatous Mitral Valve With Three-Dimensional Echocardiography.

Authors:  Alison M Pouch; Benjamin M Jackson; Eric Lai; Manabu Takebe; Sijie Tian; Albert T Cheung; Y Joseph Woo; Prakash A Patel; Hongzhi Wang; Paul A Yushkevich; Robert C Gorman; Joseph H Gorman
Journal:  Ann Thorac Surg       Date:  2016-08-01       Impact factor: 4.330

2.  Systolic characteristics and dynamic changes of the mitral valve in different grades of ischemic mitral regurgitation - insights from 3D transesophageal echocardiography.

Authors:  Caroline Morbach; Diego Bellavia; Stefan Störk; Lissa Sugeng
Journal:  BMC Cardiovasc Disord       Date:  2018-05-10       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.